Why Iron Is at the Center of RLS
Restless legs syndrome (RLS) has been linked to iron deficiency for roughly 75 years, and iron is now considered the single most important treatable factor in the condition. The connection is not about the iron circulating in your blood or the iron that prevents anemia — it is about iron in the brain.
The leading explanation is that RLS is driven by insufficient iron in specific brain regions, particularly the basal ganglia, the area that helps control movement. Iron is an essential building block for dopamine, the chemical messenger the brain uses to regulate movement. When brain iron is low, dopamine signaling is disrupted — and because dopamine activity naturally dips in the evening, this helps explain why RLS symptoms follow a daily (circadian) pattern, worsening at night.
This is why iron assessment is now considered the first and most essential step in evaluating and treating RLS, regardless of how severe the symptoms are.
The "normal blood test" problem
Here is the part that surprises most patients — and many clinicians:
Most people with RLS have blood iron markers that fall within the standard "normal" range, yet they can still have low brain iron and still benefit from iron therapy.
Researchers have confirmed reduced brain iron in people with RLS using specialized MRI, transcranial ultrasound, and spinal fluid analysis. But those tests aren't practical in everyday care, so clinicians rely on blood tests as imperfect stand-ins for brain iron. The correlation between blood iron and brain iron is loose — which is precisely why RLS uses higher iron targets than the general population. A "normal" result on a routine lab panel does not rule out an iron problem in RLS.
The Goals of Treatment
It helps to separate two related goals: the goal of iron therapy specifically, and the broader goals of RLS treatment overall.
The goal of iron therapy
The fundamental goal of iron therapy in RLS is to increase the amount of iron available to the brain. Because we can't easily measure brain iron directly, treatment is guided by raising serum iron stores (mainly ferritin and transferrin saturation) into a target range associated with symptom improvement.
A key practical point: in RLS, the aim is not simply to correct anemia or reach a bare "normal" ferritin. The targets are deliberately higher, because the objective is replenishing the brain, not just the bloodstream.
The broader goals of RLS treatment
Iron is one part of a larger plan. The overall goals of treating RLS are to:
- Reduce the frequency, duration, intensity, and timing of symptoms — for example, shifting from nightly, evening-long symptoms that delay sleep by an hour to occasional, milder episodes
- Restore sleep — difficulty falling or staying asleep is the main source of suffering in RLS, present in roughly 90% of patients
- Improve daytime function, mood, and quality of life
- Avoid the long-term complications of treatment, especially augmentation — a paradoxical, medication-induced worsening of RLS that is the main reason newer guidelines have moved away from dopamine drugs as first-line therapy
Response is best judged clinically — by comparing your symptoms before and after treatment — rather than by chasing a particular lab number.
Step One: Testing Iron the Right Way
Both the 2025 American Academy of Sleep Medicine (AASM) guideline and the 2026 RLS Foundation management algorithm agree that every patient with clinically significant RLS should have iron studies checked. The recommended panel is:
- Serum ferritin — the most accessible marker of body iron stores
- Serum iron and total iron-binding capacity (TIBC)
- Transferrin saturation (TSAT) — calculated from iron and TIBC
How the test is done matters, because it changes the result:
- Test in the morning, fasting. Iron levels swing over the day.
- Stop oral iron supplements beforehand — at least 24 hours per the AASM, and 48 hours per the RLS Foundation algorithm — because a recent dose can temporarily distort the readings.
- Be aware that ferritin is an "acute phase reactant." It rises with infection, inflammation, and some other conditions, which can make iron stores look falsely adequate. When inflammation is a concern, a low TSAT (under 20%) is a more reliable signal of true iron deficiency.
- Lab assays vary. Different ferritin tests can give meaningfully different numbers, so trends within the same lab are more useful than comparing across labs.
A complete blood count is added if ferritin or TSAT is abnormal or another blood condition is suspected.
Treatment Targets: When Iron Therapy Is Recommended
This is where the goals translate into numbers. Standard labs call ferritin "normal" above about 12–30 mcg/L. In RLS, that threshold is far too low.
Oral iron is generally considered when:
- Ferritin is at or below 75 mcg/L, or
- Transferrin saturation is below 20%
Intravenous (IV) iron and the evolving ceiling
This is one area where the two leading 2025–2026 documents differ, and it is worth understanding:
- The 2025 AASM guideline recommends oral or IV iron when ferritin is ≤ 75 mcg/L (or TSAT < 20%), and IV iron specifically when ferritin sits between 75 and 100 mcg/L.
- The 2026 RLS Foundation algorithm extends the IV iron range considerably, supporting IV iron for chronic persistent RLS with ferritin anywhere from 75 up to 300 mcg/L (with TSAT under 45%). The reasoning: newer studies suggest patients with ferritin in the 100–300 range respond to IV iron about as well as those with lower levels, and the risk of iron overload appears very low across that range.
The difference largely reflects timing — the AASM reviewed evidence through September 2023, while the RLS Foundation incorporated more recent data. The practical takeaway for patients: iron therapy may be appropriate even with a ferritin well into the "normal" range, and exact thresholds are a clinical judgment your provider will make based on your full panel, symptom severity, and overall health.
A crucial safety limit applies in both: iron should not be given when TSAT is above 45%, to avoid iron overload. A persistently high TSAT should prompt testing for hemochromatosis, a genetic iron-overload condition.
Oral Iron Therapy
Oral iron is the usual starting point when stores are low and there's no reason to skip straight to IV. A few principles make it work better and reduce side effects:
- Dose: any formulation providing about 65 mg of elemental iron (for example, ferrous sulfate 325 mg) is acceptable.
- Frequency: once a day or, preferably, every other day. This is counterintuitive but evidence-based — a dose of iron temporarily blunts absorption of the next dose for up to 48 hours, so spacing doses out actually increases total iron absorbed.
- Timing: an evening or nighttime dose may be more effective, as there's evidence iron is preferentially transported into the brain at night.
- Boost absorption: take it about two hours apart from food, calcium, magnesium, or caffeine, and consider adding 100–200 mg of vitamin C with each dose.
- If your stomach objects: GI side effects (constipation, nausea) are common. If they occur, taking iron with food is an acceptable trade-off for tolerability.
- Recheck at three months. Ferritin and symptoms are reassessed after about three months of oral iron. If symptoms remain bothersome or ferritin hasn't responded, IV iron is the next step.
Oral iron should never be taken empirically (without testing), because of the small risk of causing iron overload in someone with undiagnosed hemochromatosis. If your ferritin is below the normal range for your age and sex, your clinician should also look for why — common causes include heavy menstrual bleeding, GI bleeding, a vegan diet, frequent blood donation, or acid-reducing medications that impair absorption.
Intravenous (IV) Iron Therapy
IV iron raises iron stores quickly, bypasses the gut entirely, and is often highly effective — especially in people with genuine iron deficiency. It received a strong recommendation from the AASM for the preparation ferric carboxymaltose in appropriately selected patients.
When IV iron is preferred
- Oral iron isn't absorbed well (GI disease, prior bariatric/bypass surgery, celiac disease, inflammatory bowel disease)
- Oral iron isn't tolerated because of side effects
- RLS hasn't improved after about three months of oral iron
- Symptoms are severe enough that a rapid response is needed
- Ferritin sits in a range where oral iron is poorly absorbed (roughly 75–300 mcg/L)
The main preparations
Formulations that release iron slowly are preferred, because they allow fewer infusions and better brain penetration. Four fit this profile:
- Ferric carboxymaltose — the best-studied for RLS (the only one with placebo-controlled trials) and strongly recommended
- Low-molecular-weight iron dextran
- Ferumoxytol
- Ferric derisomaltose
Choice among them comes down to availability, cost, ease of administration, and side-effect profile.
Safety and what to expect
- Hypophosphatemia (low blood phosphate) occurs in roughly 40–70% of adults given ferric carboxymaltose. It's usually silent, but matters with repeated infusions or very low baseline iron; an alternative preparation can be used if needed.
- Serious allergic reactions are rare (about 1 in 200,000), but infusions should still be given in a setting equipped for resuscitation, ideally an infusion center.
- Minor infusion reactions (such as facial flushing) are managed by pausing and slowing the infusion. Notably, antihistamines should not be used as premedication — their side effects can mimic infusion reactions and can themselves worsen RLS.
- Be patient. The response to IV iron can take 6 to 8 weeks. Because of this, people with severe, distressing symptoms may start or adjust other RLS therapy in parallel rather than waiting on iron alone.
There is generally no specific "target" ferritin number to chase after an infusion, and routine retesting right afterward isn't usually necessary (levels almost always rise). Iron studies are rechecked mainly when symptoms return and a repeat infusion is being considered — and before repeating, ferritin should be ≤ 300 mcg/L and TSAT < 45%.
Iron in Special Situations
- Children: iron is the mainstay of pediatric RLS treatment. Supplementation is considered when ferritin is below 50 mcg/L, with oral iron first and IV iron (commonly ferric carboxymaltose) if oral therapy fails or isn't tolerated.
- Pregnancy: RLS is common in pregnancy, and optimizing iron is central to management. Iron criteria are the same as for other adults, but IV iron is generally avoided in the first trimester due to limited safety data; it may be used in the second and third trimesters when indicated.
- End-stage kidney disease (dialysis): iron deficiency is frequent and should be treated. In this group, IV iron sucrose is supported when ferritin is under 200 mcg/L and TSAT under 20%.
Where Iron Fits in the Overall Plan
Iron is the foundation, not the whole house. The current first-line approach to chronic persistent RLS is, in order:
- Optimize iron (and address aggravating factors — alcohol, caffeine, certain antidepressants and antihistamines, and untreated sleep apnea)
- Add an alpha-2-delta ligand (gabapentin, gabapentin enacarbil, or pregabalin) if symptoms still need treatment
Dopamine agonists, once first-line, are now reserved for selected cases because of the high long-term risk of augmentation. For a fuller picture of the medication options, see our companion guide, Treating Restless Legs Syndrome: What the Latest Guidelines Recommend.
Key Takeaways
- RLS is, at its core, often a brain-iron problem — low iron in the basal ganglia disrupts the dopamine that controls movement.
- Normal blood tests don't rule it out. Brain iron can be low even when standard labs look fine, so RLS uses higher iron targets.
- The goal of iron therapy is to replenish brain iron, not merely to correct anemia or reach a minimal "normal" ferritin.
- Everyone with significant RLS should have ferritin and transferrin saturation checked — fasting, in the morning, off iron supplements beforehand.
- Treat when ferritin is ≤ 75 mcg/L or TSAT < 20%; IV iron may be appropriate at higher ferritin levels (up to ~300 mcg/L in the latest algorithm).
- Oral iron: ~65 mg elemental iron, every other day, with vitamin C; reassess at three months.
- IV iron (especially ferric carboxymaltose) works quickly and is strongly recommended for the right patients, but the symptom benefit can take 6–8 weeks.
- Never supplement iron empirically — test first, because too much iron is harmful.
- Iron is the first step, not the only step — many people also need an alpha-2-delta ligand for full control.